Prioritisation by physicians in the Netherlands-The growth hormone example in drug reimbursement decisions

Health Policy

Volumn 80, Issue 3, 2007, Pages 369-377

  de Bont, Antoinette ^a   Zandwijken, Gladys ^b   Stolk, Elly ^a   Niessen, Louis ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Dutch Growth Foundation   (Netherlands)

Author keywords

Drug reimbursement; Growth hormone; Guidelines; Prioritisation; The Netherlands

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; ANTIRETROVIRUS AGENT; BECAPLERMIN; CLOPIDOGREL; COLONY STIMULATING FACTOR; GABAPENTIN; GROWTH HORMONE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PALIVIZUMAB; PNEUMOCOCCUS VACCINE; RIVASTIGMINE;

ARTICLE; CONFLICT; DISEASE CLASSIFICATION; GROWTH HORMONE DEFICIENCY; HEALTH INSURANCE; HUMAN; MEDICAL AUDIT; MEDICAL DECISION MAKING; NETHERLANDS; PEDIATRICIAN; PRACTICE GUIDELINE; QUALITATIVE RESEARCH; REIMBURSEMENT; SEMI STRUCTURED INTERVIEW;

CHOICE BEHAVIOR; FOCUS GROUPS; GROWTH HORMONE; HEALTH CARE RATIONING; HUMANS; INTERVIEWS; NATIONAL HEALTH PROGRAMS; NETHERLANDS; PHYSICIANS; REIMBURSEMENT MECHANISMS;

EID: 33846223333     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2006.03.016     Document Type: Article

References (13)

1. Ham C., and Robbert G. Reasonable rationing. International experience of priority setting in health care (2003), Open University Press, Maidenhead
2. Daniels N., and Sabin J. Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philosophy and Public Affairs 26 4 (1997) 303-350
3. Ham C. Tragic choices in health care: lessons from the child B case. BMJ 319 (1999) 1258-1261
4. Martin D., Giacomini M., and Singer P. Fairness, accountability for reasonableness and views of priority setting decisions-makers. Health Policy 61 3 (2002) 279-290
5. Niessen L.W., Grijseels E., and Rutten F.F.H. The evidence-based approach in health policy and practice. Social Science and Medicine 51 6 (2000) 859-869
6. Vuorenkoski L., Toiviainen H., and Hemminki E. Drug reimbursement in Finland-a case of explicit prioritizing in special categories. Health Policy 66 (2003) 169-177
7. Berg M., Grinten van der T., and Klazinga N. Technology assessment, priority setting, and appropriate care in Dutch health care. International Journal of Technology Assessment in Health Care 20 1 (2004) 25-43
8. Norheim O. Healthcare rationing-are additional criteria needed for assessing evidence based clinical practice guidelines?. BMJ 319 (1999) 1426-1429
9. CVZ. Business plan "Landelijke beoordelingsorganisatie aanspraak geneesmiddelen" (2004), CVZ, Amstelveen [in Dutch]
10. Ziekenfondsraad. Protocol gebruik groeihormoon. Amstelveen: CURE/CR3.87; 1997 [in Dutch].
11. CBO. Consensus diagnostiek kleine lichaamslengte bij kinderen (1997), CBO, Utrecht. http://www.cbo.nl/product650/richtlijnen/pdf/lichaamslengte http://www.cbo.nl/product650/richtlijnen/pdf/lichaamslengte [in Dutch]
12. Ziekenfondsraad. Rapport doelmatig gebruik groeihormoon. Amstelveen: 1996/717 [in Dutch].
13. College voor Zorgverzekeringen. Evaluatie Landelijke Beoordelingen en Registratie Groeihormoon. Diemen: 2004/ 2453068d. Rapport doelmatig gebruik groeihormoon. Amstelveen: 1996/717 [in Dutch].